Federal Register Notice: FDA is seeking public comment on regulations requiring the distribution of patient labeling, called Medication Guides, for certain products that pose a serious and significant public health concern requiring distribution of FDA-approved patient medication information. Comments should be submitted by 3/14. To view this notice, click here.
